Medicine and Dentistry
Optical Coherence Tomography
87%
Bevacizumab
75%
Ptosis
67%
Upper Eyelid
66%
Best Corrected Visual Acuity
59%
Age Related Macular Degeneration
50%
Visual Acuity
46%
Odds Ratio
41%
Cataract
34%
Pediatrics
33%
Neoplasm
33%
Wet Macular Degeneration
32%
Refractive Surgery
32%
Ophthalmology
30%
Recurrent Disease
29%
Choroidal Neovascularization
28%
LASIK
28%
Lid
28%
Subretinal Fluid
26%
Surgeon
25%
Ocular Surface
24%
Chalazion
24%
Photorefractive Keratectomy
24%
Ptosis Repair
24%
Visual Impairment
24%
Prevalence
24%
Optic Nerve
23%
Eyelash
23%
Obstruction
22%
Photograph
22%
Ptosis (Eyelid)
21%
Retinal Nerve Fiber Layer
21%
Mitomycin
21%
Dacryocystorhinostomy
21%
Orbital Cellulitis
21%
Canthus
21%
Sensation
21%
Dermatochalasis
21%
Suture
21%
Oculoplastics
21%
Blepharoplasty
19%
Cataract Surgery
19%
Contralateral
19%
Refractive Error
18%
Intravitreal Administration
18%
Student T Test
17%
Diseases
17%
Retinal Detachment
17%
Anisometropia
17%
Paralysis
17%
Keyphrases
Eyelid
100%
Best-corrected Visual Acuity
56%
Age-related Macular Degeneration
56%
Associated Morbidity
54%
Intravitreal Ranibizumab
50%
Odds Ratio
50%
Bevacizumab
45%
Optical Coherence Tomography
45%
Visual Acuity
41%
Upper Eyelid
41%
Neovascular Age-related Macular Degeneration (nAMD)
34%
Risk Factors
32%
Large Community
32%
Community-based
32%
Subretinal Fluid
30%
Israel
30%
LASIK
28%
Chalazion
25%
Cataract
25%
Pterygium
24%
Cataract Surgery
24%
Ptosis
24%
Myasthenia Gravis
23%
Intravitreal Injection
23%
Photorefractive Keratectomy
23%
Cataract Patients
23%
Response Predictors
23%
Etiology
23%
Spectral Domain Optical Coherence Tomography (SD-OCT)
23%
Macular Volume
22%
Eyelid Surgery
22%
Consecutive Patients
22%
Peripapillary Choroidal Neovascularization
21%
Eyelashes
21%
Mitomycin C
21%
Thickness Measurement
21%
Microkeratome
21%
Orbital Cellulitis
21%
Novel Technique
21%
Signal Strength
21%
Hering's Law
21%
Sensory Changes
21%
Refractive Surgery
21%
Confidence Interval
20%
Excision
19%
Flap
19%
Congenital Nasolacrimal Duct Obstruction (CNLDO)
19%
Cornea
17%
Refractive Error
17%
Intravitreal Bevacizumab
17%